lobbying_activities: 2820487

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2820487	ca65d829-202a-4008-8d87-51e245b35075	Q2	GOVERNMENT COUNSEL, LLC	401105070	HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS)	2022	second_quarter	MED	S.2209/H.R.4128-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, and H.R. 7667, Food and Drug Amendments of 2022, relating to the establishment of a regulatory framework for laboratory developed tests.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2022-07-15T12:54:30-04:00